Jason D. Merker

Tumor Cell-Free DNA Assay Analytical Performance in 101 Clinical Laboratories Participating in a College of American Pathologists Proficiency Testing Program

Tumor cell-free DNA (cfDNA) assays are increasingly used for mutation detection in therapy selection and disease monitoring. This study evaluates the laboratory performance in College of American Pathologists (CAP) Molecular Oncology Committee tumor cfDNA proficiency testing (PT) during a 2-year period. To a...